Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Lymecycline Action Pathway
Homo sapiens
Drug Action Pathway
Created: 2013-08-22
Last Updated: 2025-01-29
Lymecycline is a tetracycline antibiotic that inhibits cell growth by inhibiting translation. Lymecycline is lipophilic and can diffuse across bacterial cell membranes or travel through membrane porin channels. Once inside the bacterial cell, it reversibly binds to the bacterial 30S ribosomal subunit and prevents aminoacyl tRNA from binding to the A site of the ribosome-RNA complex; aminoacyl tRNA binding inhibition likely occurs through steric hindrance. This results in inhibition of bacterial protein synthesis and hence cell growth.
References
Lymecycline Pathway References
Song, K.S. Ribosomal protein synthesis inhibitors. In S. Offermanns, & W. Rosenthal (Eds.). Encyclopedic reference of molecular pharmacology. (2004) p. 827-833. Berlin, Germany: Springer.
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
No Proteins Present
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
No Proteins Present
Downloads
Settings